drug · small molecule
lumacaftor
Phase 2updated 3mo agoby Qanatpharma AG🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for cystic fibrosis and acute lung injury and 3 investigational indications.
targets
Cystic fibrosis transmembrane conductance regulator
all catalysts(0)
nothing on the calendar yet
Trials studying lumacaftor
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that